AMENDMENT NO. 7 TO COLLABORATION AND OPTION AGREEMENTAnd Option Agreement • May 4th, 2015 • Cytokinetics Inc • Pharmaceutical preparations
Contract Type FiledMay 4th, 2015 Company IndustryThis Amendment No. 7 to the Agreement (this “Amendment No. 7”) is entered into as of March 19, 2015 (the “Amendment Effective Date”) by and between Cytokinetics, Incorporated (“Cytokinetics” or “CK”), a Delaware corporation, having its principal place of business at 280 East Grand Ave., South San Francisco, California 94080 and Amgen Inc., a Delaware corporation having its principal place of business at One Amgen Center Drive, Thousand Oaks, California 91320 (“Amgen”).